To determine if WSX1 expression in tumor cells affects their ability to secrete IFNγ, tumors and splenocytes were co-incubated and the percentage of CD4+ and CD8+ cells expressing IFNγ was determined. This evidence concerns the gene CD8A and neoplasm.